SlideShare una empresa de Scribd logo
1 de 8
Visualize the pharma twittersphere



jeudi, 21 janvier 2010
Pfizer leads in terms of followers despite a late start; GSKUS most
           impresssive growth (77% vs 51% on average)

  #
of
Followers




                                                                                                     
2
699




                                                                                                     1
313




                              Avg
Dec
09
                              Avg
Jul
09

                         Source:
www.twi-er.com,
July
13th
and
Dec
31st
2009;
whdotpharma
analysis

jeudi, 21 janvier 2010
Great divide on following policy amongst pharma twitter accounts –
       question of “social media maturity“?

            #
of
Following




                                                                                                     
600

                                                                                                     392




                              Avg
Dec
09
                              Avg
Jul
09
                         Source:
www.twi-er.com,
July
13th
and
Dec
31st
2009;
whdotpharma
analysis

jeudi, 21 janvier 2010
Great divide also on activity – indicator for degree of engagement?

        #
of
Updates




                                                                                                     
255


                                                                                                     119




                              Avg
Dec
09
                              Avg
Jul
09

                         Source:
www.twi-er.com,
July
13th
and
Dec
31st
2009;
whdotpharma
analysis

jeudi, 21 janvier 2010
Boehringer and JNJ track above average in terms of engagement

     #
of
Following




                                                     The twitter engagement
                                                     quardrant: above
                                                     average followers,
                                                     following and updates!
                 Average
following:
392




                                  Average
Updates:
119                                                                #
of
Updates
                                                                                       Bubble
size
=
#
of
followers
                         Source:
www.twi-er.com,
July
13th
and
Dec
31st
2009;
whdotpharma
analysis

jeudi, 21 janvier 2010
... Roche and AstraZeneca moving into the “engagement“ quardrant

      #
of
Following




                             @Pfizer_news



                          Avrg
following:
600

                         @genentechnews




                                            Avrg
Updates:
255                                                                #
of
Updates
                                                                                         Avrg
Bubble
size
=
#
of
followers
                           Source:
www.twi-er.com,
July
13th
and
Dec
31st
2009;
whdotpharma
analysis

jeudi, 21 janvier 2010
26% of Boehringer followers are large accounts (>500 followers) vs. only
              14% for Novartis - less is more?

                                                                                                   Number of    % with >500
                                                                                                   followers    followers


                                                                                                     3 941      15%

                                                                                                     3 865      14%

                                                                                                     3 304      26%

                                                                                                     2 780      20%

                                                                                                     2 574      20%

                                                                                                          Avrg 19%

       Number of followers that
       are followed by




              19% of pharma followers (roughly 3000 accounts) are large accounts (>500 followers).
              The segmentation and profiling of these accounts, will be the basis of Part II of this analysis.


                         Source:
www.twi-er.com,
Dec
31st
2009;
whdotpharma
analysis


jeudi, 21 janvier 2010
Coming to whydotpharma soon:
                         the mapping of the pharma twittersphere!




                                                        Stay tuned!

jeudi, 21 janvier 2010

Más contenido relacionado

Destacado (6)

Eric Hotfelter Resume (1)
Eric Hotfelter Resume (1)Eric Hotfelter Resume (1)
Eric Hotfelter Resume (1)
 
Catedral de lima presentacion-touro
Catedral de lima   presentacion-touroCatedral de lima   presentacion-touro
Catedral de lima presentacion-touro
 
CompTIA A+ ce certificate
CompTIA A+ ce certificateCompTIA A+ ce certificate
CompTIA A+ ce certificate
 
Contro presupuestario dapositivas
Contro presupuestario dapositivasContro presupuestario dapositivas
Contro presupuestario dapositivas
 
TwistedMinds.in
TwistedMinds.inTwistedMinds.in
TwistedMinds.in
 
La carta que tu hijo adolescente no te puede escribir
La carta que tu hijo adolescente no te puede escribirLa carta que tu hijo adolescente no te puede escribir
La carta que tu hijo adolescente no te puede escribir
 

Más de Silja Chouquet

Infographic Healthcare Archetypes of conversation
Infographic Healthcare Archetypes of conversation Infographic Healthcare Archetypes of conversation
Infographic Healthcare Archetypes of conversation
Silja Chouquet
 
A healthcare case study of ASCO, Novartis and Boehringer conversation on twitter
A healthcare case study of ASCO, Novartis and Boehringer conversation on twitterA healthcare case study of ASCO, Novartis and Boehringer conversation on twitter
A healthcare case study of ASCO, Novartis and Boehringer conversation on twitter
Silja Chouquet
 
HCSMEU Mission statement
HCSMEU Mission statementHCSMEU Mission statement
HCSMEU Mission statement
Silja Chouquet
 
3 3 Globalization Kalyanpur
3 3 Globalization Kalyanpur3 3 Globalization Kalyanpur
3 3 Globalization Kalyanpur
Silja Chouquet
 
3 2 Globalization Schweitzer
3 2 Globalization Schweitzer3 2 Globalization Schweitzer
3 2 Globalization Schweitzer
Silja Chouquet
 
3 1 Globalization Hoogland
3 1 Globalization Hoogland3 1 Globalization Hoogland
3 1 Globalization Hoogland
Silja Chouquet
 
2 3 Consumer Gritschneder
2 3 Consumer Gritschneder2 3 Consumer Gritschneder
2 3 Consumer Gritschneder
Silja Chouquet
 

Más de Silja Chouquet (20)

Revealing ASCO's social DNA
Revealing ASCO's social DNARevealing ASCO's social DNA
Revealing ASCO's social DNA
 
Biosimilars discussion on Twitter
Biosimilars discussion on TwitterBiosimilars discussion on Twitter
Biosimilars discussion on Twitter
 
Infographic Healthcare Archetypes of conversation
Infographic Healthcare Archetypes of conversation Infographic Healthcare Archetypes of conversation
Infographic Healthcare Archetypes of conversation
 
A healthcare case study of ASCO, Novartis and Boehringer conversation on twitter
A healthcare case study of ASCO, Novartis and Boehringer conversation on twitterA healthcare case study of ASCO, Novartis and Boehringer conversation on twitter
A healthcare case study of ASCO, Novartis and Boehringer conversation on twitter
 
Three things to know about pharma and twitter
Three things to know about pharma and twitterThree things to know about pharma and twitter
Three things to know about pharma and twitter
 
Ideagoras
IdeagorasIdeagoras
Ideagoras
 
Impact of social media on patient adherence
Impact of social media on patient adherenceImpact of social media on patient adherence
Impact of social media on patient adherence
 
Pecha kucha
Pecha kuchaPecha kucha
Pecha kucha
 
Digipharm workshop2011
Digipharm workshop2011Digipharm workshop2011
Digipharm workshop2011
 
20110126smiwhydotpresentation
20110126smiwhydotpresentation20110126smiwhydotpresentation
20110126smiwhydotpresentation
 
20100906 hcsmeu digipharmpres
20100906 hcsmeu digipharmpres20100906 hcsmeu digipharmpres
20100906 hcsmeu digipharmpres
 
Kalkscheune
KalkscheuneKalkscheune
Kalkscheune
 
HCSMEU Mission statement
HCSMEU Mission statementHCSMEU Mission statement
HCSMEU Mission statement
 
Powervote Results
Powervote ResultsPowervote Results
Powervote Results
 
HCSMEU Mission statement
HCSMEU Mission statementHCSMEU Mission statement
HCSMEU Mission statement
 
3 3 Globalization Kalyanpur
3 3 Globalization Kalyanpur3 3 Globalization Kalyanpur
3 3 Globalization Kalyanpur
 
3 2 Globalization Schweitzer
3 2 Globalization Schweitzer3 2 Globalization Schweitzer
3 2 Globalization Schweitzer
 
3 1 Globalization Hoogland
3 1 Globalization Hoogland3 1 Globalization Hoogland
3 1 Globalization Hoogland
 
2 3 Consumer Gritschneder
2 3 Consumer Gritschneder2 3 Consumer Gritschneder
2 3 Consumer Gritschneder
 
Gto Consumer Apelles
Gto Consumer ApellesGto Consumer Apelles
Gto Consumer Apelles
 

Último

Artificial Intelligence: Facts and Myths
Artificial Intelligence: Facts and MythsArtificial Intelligence: Facts and Myths
Artificial Intelligence: Facts and Myths
Joaquim Jorge
 

Último (20)

presentation ICT roal in 21st century education
presentation ICT roal in 21st century educationpresentation ICT roal in 21st century education
presentation ICT roal in 21st century education
 
GenAI Risks & Security Meetup 01052024.pdf
GenAI Risks & Security Meetup 01052024.pdfGenAI Risks & Security Meetup 01052024.pdf
GenAI Risks & Security Meetup 01052024.pdf
 
04-2024-HHUG-Sales-and-Marketing-Alignment.pptx
04-2024-HHUG-Sales-and-Marketing-Alignment.pptx04-2024-HHUG-Sales-and-Marketing-Alignment.pptx
04-2024-HHUG-Sales-and-Marketing-Alignment.pptx
 
A Domino Admins Adventures (Engage 2024)
A Domino Admins Adventures (Engage 2024)A Domino Admins Adventures (Engage 2024)
A Domino Admins Adventures (Engage 2024)
 
Artificial Intelligence: Facts and Myths
Artificial Intelligence: Facts and MythsArtificial Intelligence: Facts and Myths
Artificial Intelligence: Facts and Myths
 
Strategies for Landing an Oracle DBA Job as a Fresher
Strategies for Landing an Oracle DBA Job as a FresherStrategies for Landing an Oracle DBA Job as a Fresher
Strategies for Landing an Oracle DBA Job as a Fresher
 
Scaling API-first – The story of a global engineering organization
Scaling API-first – The story of a global engineering organizationScaling API-first – The story of a global engineering organization
Scaling API-first – The story of a global engineering organization
 
HTML Injection Attacks: Impact and Mitigation Strategies
HTML Injection Attacks: Impact and Mitigation StrategiesHTML Injection Attacks: Impact and Mitigation Strategies
HTML Injection Attacks: Impact and Mitigation Strategies
 
Handwritten Text Recognition for manuscripts and early printed texts
Handwritten Text Recognition for manuscripts and early printed textsHandwritten Text Recognition for manuscripts and early printed texts
Handwritten Text Recognition for manuscripts and early printed texts
 
Axa Assurance Maroc - Insurer Innovation Award 2024
Axa Assurance Maroc - Insurer Innovation Award 2024Axa Assurance Maroc - Insurer Innovation Award 2024
Axa Assurance Maroc - Insurer Innovation Award 2024
 
Real Time Object Detection Using Open CV
Real Time Object Detection Using Open CVReal Time Object Detection Using Open CV
Real Time Object Detection Using Open CV
 
Driving Behavioral Change for Information Management through Data-Driven Gree...
Driving Behavioral Change for Information Management through Data-Driven Gree...Driving Behavioral Change for Information Management through Data-Driven Gree...
Driving Behavioral Change for Information Management through Data-Driven Gree...
 
Mastering MySQL Database Architecture: Deep Dive into MySQL Shell and MySQL R...
Mastering MySQL Database Architecture: Deep Dive into MySQL Shell and MySQL R...Mastering MySQL Database Architecture: Deep Dive into MySQL Shell and MySQL R...
Mastering MySQL Database Architecture: Deep Dive into MySQL Shell and MySQL R...
 
🐬 The future of MySQL is Postgres 🐘
🐬  The future of MySQL is Postgres   🐘🐬  The future of MySQL is Postgres   🐘
🐬 The future of MySQL is Postgres 🐘
 
Bajaj Allianz Life Insurance Company - Insurer Innovation Award 2024
Bajaj Allianz Life Insurance Company - Insurer Innovation Award 2024Bajaj Allianz Life Insurance Company - Insurer Innovation Award 2024
Bajaj Allianz Life Insurance Company - Insurer Innovation Award 2024
 
How to Troubleshoot Apps for the Modern Connected Worker
How to Troubleshoot Apps for the Modern Connected WorkerHow to Troubleshoot Apps for the Modern Connected Worker
How to Troubleshoot Apps for the Modern Connected Worker
 
Apidays New York 2024 - Scaling API-first by Ian Reasor and Radu Cotescu, Adobe
Apidays New York 2024 - Scaling API-first by Ian Reasor and Radu Cotescu, AdobeApidays New York 2024 - Scaling API-first by Ian Reasor and Radu Cotescu, Adobe
Apidays New York 2024 - Scaling API-first by Ian Reasor and Radu Cotescu, Adobe
 
AWS Community Day CPH - Three problems of Terraform
AWS Community Day CPH - Three problems of TerraformAWS Community Day CPH - Three problems of Terraform
AWS Community Day CPH - Three problems of Terraform
 
Connector Corner: Accelerate revenue generation using UiPath API-centric busi...
Connector Corner: Accelerate revenue generation using UiPath API-centric busi...Connector Corner: Accelerate revenue generation using UiPath API-centric busi...
Connector Corner: Accelerate revenue generation using UiPath API-centric busi...
 
Developing An App To Navigate The Roads of Brazil
Developing An App To Navigate The Roads of BrazilDeveloping An App To Navigate The Roads of Brazil
Developing An App To Navigate The Roads of Brazil
 

Whydot Pharma Twittersphere Mapping Jan 09

  • 1. Visualize the pharma twittersphere jeudi, 21 janvier 2010
  • 2. Pfizer leads in terms of followers despite a late start; GSKUS most impresssive growth (77% vs 51% on average) #
of
Followers 
2
699 1
313 Avg
Dec
09 Avg
Jul
09 Source:
www.twi-er.com,
July
13th
and
Dec
31st
2009;
whdotpharma
analysis jeudi, 21 janvier 2010
  • 3. Great divide on following policy amongst pharma twitter accounts – question of “social media maturity“? #
of
Following 
600 392 Avg
Dec
09 Avg
Jul
09 Source:
www.twi-er.com,
July
13th
and
Dec
31st
2009;
whdotpharma
analysis jeudi, 21 janvier 2010
  • 4. Great divide also on activity – indicator for degree of engagement? #
of
Updates 
255 119 Avg
Dec
09 Avg
Jul
09 Source:
www.twi-er.com,
July
13th
and
Dec
31st
2009;
whdotpharma
analysis jeudi, 21 janvier 2010
  • 5. Boehringer and JNJ track above average in terms of engagement #
of
Following The twitter engagement quardrant: above average followers, following and updates! Average
following:
392 Average
Updates:
119 #
of
Updates Bubble
size
=
#
of
followers Source:
www.twi-er.com,
July
13th
and
Dec
31st
2009;
whdotpharma
analysis jeudi, 21 janvier 2010
  • 6. ... Roche and AstraZeneca moving into the “engagement“ quardrant #
of
Following @Pfizer_news Avrg
following:
600 @genentechnews Avrg
Updates:
255 #
of
Updates Avrg
Bubble
size
=
#
of
followers Source:
www.twi-er.com,
July
13th
and
Dec
31st
2009;
whdotpharma
analysis jeudi, 21 janvier 2010
  • 7. 26% of Boehringer followers are large accounts (>500 followers) vs. only 14% for Novartis - less is more? Number of % with >500 followers followers 3 941 15% 3 865 14% 3 304 26% 2 780 20% 2 574 20% Avrg 19% Number of followers that are followed by 19% of pharma followers (roughly 3000 accounts) are large accounts (>500 followers). The segmentation and profiling of these accounts, will be the basis of Part II of this analysis. Source:
www.twi-er.com,
Dec
31st
2009;
whdotpharma
analysis jeudi, 21 janvier 2010
  • 8. Coming to whydotpharma soon: the mapping of the pharma twittersphere! Stay tuned! jeudi, 21 janvier 2010